XML 26 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2017
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 305,076 $ 291,622 $ 110,631
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation, depletion, and amortization 225,921 178,332 188,142
Deferred income taxes (6,511) (24,722) 31,274
Share-based compensation 23,965 22,187 18,794
Loss on the disposal of property, plant, equipment, and intangibles, net 924 2,582 760
Loss (Gain) on Disposition of Business (1,370) 14,547 [1] 86,574 [1]
Goodwill, Impairment Loss 0 0 58,356 [2]
Other items (18,397) 32,229 (13,242)
Changes in operating assets and liabilities:      
Accounts receivable, net (48,486) (37,731) (48,140)
Inventories, net (14,617) (5,178) (12,829)
Other current assets (7,371) (1,244) 2,324
Accounts payable 21,244 563 6,884
Accruals and other, net 59,127 (15,555) (5,442)
Net cash provided by operating activities 539,505 457,632 424,086
Investing activities:      
Purchases of property, plant, equipment, and intangibles, net (189,715) (165,457) (172,901)
Proceeds from the sale of property, plant, equipment, and intangibles 5,567 2,094 4,846
Proceeds from Divestiture of Businesses 2,478 8,888 135,713
Payments to Acquire Investments (4,955) 0 (6,356)
Investments in businesses, net of cash acquired (13,313) (46,271) (65,557)
Payments for (Proceeds from) Other Investing Activities (13,286) (3,083) 0
Net cash used in investing activities (213,224) (203,829) (104,255)
Financing activities:      
Proceeds from Issuance of Private Placement 0 0 293,730
Repayments of Long-term Debt (85,000) (222,500) (172,500)
Proceeds Under Credit Facility, net (27,087) 29,065 (196,613)
Amortization of Financing Costs (488) (2,029) (1,073)
Payments of Merger Related Costs, Financing Activities (1,327) (2,064) (9,918)
Repurchases of ordinary shares (81,494) (65,485) (97,509)
Cash dividends paid to common shareholders (112,503) (102,929) (93,193)
Proceeds from Issuance or Sale of Equity 0 0 5,022
Stock option and other equity transactions, net 13,107 9,758 4,955
Net cash (used in) provided by financing activities (294,792) (356,184) (267,099)
Effect of exchange rate changes on cash and cash equivalents (12,390) 20,997 (18,655)
Increase (Decrease) in cash and cash equivalents 19,099 (81,384) 34,077
Cash and cash equivalents at beginning of period 201,534 282,918 248,841
Cash and cash equivalents at end of period $ 220,633 $ 201,534 $ 282,918
[1] For more information regarding our goodwill impairment loss see Note 3 titled, "Goodwill and Intangible Assets".
[2] For more information regarding our goodwill impairment loss see Note 3 titled, "Goodwill and Intangible Assets"